iimveliso

I-zinc picolinate (17949-65-4)

I-Zinc Picolinate yityuwa ye-ionic ye-zinc kunye ne-picolinic acid. Esi songezelelo sinokubonelela ngomzimba ngezimbiwa, izinc. Esi songezelelo sinama-20% ezinc zinc ngokobunzima, oko kuthetha ukuba i-100 milligrams ye-zinc picolinate iya kuvelisa i-20 milligrams ye-zinc.

I-Zinc isebenza njenge-cofactor yee-enzymes ezininzi, kubandakanya ukuhlanganiswa kweprotein, ukuveliswa kwe-insulin kunye nokukhula kwengqondo. Ngaphandle kokubaluleka kwale minerali, imizimba yethu ayinakugcina i-Zinc egqithisileyo njengoko isenza ngokwendalo nezinye iiminerali kunye neevithamini. I-Zinc Picolinate yifom ye-asidi yeZinc umzimba womntu onokuyifumana ngokulula kunezinye iintlobo zeZinc.

Umgubo wobulumko unamandla okuvelisa nokubonelela ngobuninzi. Yonke imveliso phantsi kwemeko ye-cGMP kunye nenkqubo engqongqo yokulawula umgangatho, onke amaxwebhu okuvavanya kunye nesampuli ekhoyo.
Udidi:

IZinc picolinate Ulwazi lweeChemical Base

igama IZinc picolinate
CAS 17949-65-4
Ukungcola 98%
Igama leKhemikhali IZinc picolinate
Iintetho ezifanayo IZINC PICOLINATE; I-Picolinic acid zinc; ZINCPICOLINATE, umgubo; IZINTO ZE-PICOLINIC ACID ZINC SALT; I-zinc 2-pyridinecarboxylate; zinc, pyridine-2-carboxylate; IZINC PICOLINATE CAS 17949-65-4; I-zinc zinc i-ISO 9001: 2015 FINYELELA; Zinc Picolinate, 200-400 enemingxuma, Powder; I-Zinc, i-bis (2-pyridinecarboxylato-.kappa.N1, .kappa.O2) -, (T-4) -
I-Molecular Formula I-C12H8N2O4Zn
Isisindo somzimba 309.58
Indawo yeBoling 292.5ºC kwi-760 mmHg
InChI Key I-NHVUUBRKFZWXRN-UHFFFAOYSA-L
imo solid
Kubonakala Powder
Ubomi obulicla /
Umzimba I-Soluble emanzini
yoGcino Imeko Gcina kwi-RT.
isicelo Isetyenziswa njengesongezelelo sokutya okunesondlo njengomthombo we-zinc kunye ne-aspartic acid.
UXwebhu loVavanyo iyafumaneka

 

I-Zinc picolinate powder 17949-65-4 Inkcazelo ngokubanzi

I-Zinc Picolinate sisongezo sokutya se-zinc esine-zinc ityuwa ye-picolinic acid, enokusetyenziselwa ukuthintela okanye ukunyanga ukusilela kwe-zinc, kunye nomsebenzi we-immunomodulatory. Emva kolawulo, i-zinc picolinate yongeza i-zinc. Njengento ebalulekileyo yokulandelela, i-zinc ibaluleke kakhulu kwiinkqubo ezininzi zebhayoloji. Idlala indima ebalulekileyo ekusebenzeni ngendlela efanelekileyo kwamajoni omzimba angaphakathi kunye nolungelelwaniso. I-Zinc inqanda ukuveliswa kwabalamli abanomdla wokuthintela kunye nokuthintela ukudumba. Isebenza njenge-antioxidant, ithintela umonakalo we-oxidative kwaye ikhusela iiseli kumonakalo we-DNA. I-Zinc iyadingeka kwimisebenzi ye-enzyme eyimfuneko ukwahlulwa kweseli, ukukhula kweseli, kunye nokuphilisa inxeba.

 

I-Zinc picolinate powder 17949-65-4 isicelo

  1. Isiyobisi, ukongezwa kwendlela yokutya, amayeza ahambelana noko
  2. Ukutya okongezayo, kubandakanya iziqholo, izicatshulwa, imibala, iincasa, njl njl. Kongezwe ukutya okusetyenziswa ngabantu
  3. Ukhathalelo lomntu, iimveliso zokhathalelo lomntu, kubandakanya nezithambiso, ishampu, iziqholo, iisepha, into yokuthambisa, izinto zokuthambisa, njl.
  4. Ukunyamekelwa, izithambiso, ukuthintelwa iYurophu, iikhemikhali kuluhlu luxhomekeke kuthintelo losetyenziso (okt ezinye izinto zivunyelwe, kodwa ukusetyenziswa kunqunyelwe) eYurophu

 

I-Zinc picolinate powder 17949-65-4 Uphando ngakumbi

I-Zinc picolinate yityuwa ye-zinc ye-picolinic acid. Iyafumaneka njengezongezelelo zokutya ze-OTC njengomthombo we-zinc ukunyanga nokukhusela ukusilela kwe-zinc. Ukufakwa kwe-zinc emva kolawulo lomlomo lwe-zinc picolinate kubonisiwe kuyasebenza.

 

isingqiniso

[1] Ukuqonda okutsha kwi-tryptophan kunye nemetabolites yayo kulawulo lweethambo metabolism.Michalowska M1, Znorko B2, Kaminski T1, Oksztulska-Kolanek E2, Pawlak D3. J iPhysiol Pharmacol. NgoDisemba ka-2015; 66 (6): 779-91.

[2] I-Barrie SA, i-Wright JV, i-Pizzorno JE, i-Kutter E, i-PC ye-Barron: Ukuthelekiswa kwe-zinc picolinate, i-zinc citrate kunye ne-zinc gluconate ebantwini. Izenzo zeearhente. Ngo-1987 ngoJuni; 21 (1-2): 223-8.

[3] Uvavanyo lwe-anticonvulsant potency ye-benzylamide derivatives ezahlukeneyo kwimodeli yokubamba ye-electroshock-induction. Świąder MJ1, Paruszewski R2, Łuszczki JJ3. IPhemacol Rep. 2016 Epreli; 68 (2): 259-62.

 

Amanqaku aKhanyayo